Back | Next |
home / stock / fldm / fldm message board
Subject | By | Source | When |
---|---|---|---|
This entire sector has been down $OPK as well | jonsmile | investorshub | 09/02/2020 3:14:55 PM |
You here for short gains? That streak would | Ckasper | investorshub | 09/02/2020 3:13:00 PM |
LOL counting those chickens I see | jonsmile | investorshub | 09/02/2020 3:10:26 PM |
For now | Ckasper | investorshub | 09/02/2020 3:10:07 PM |
But its red LOL | jonsmile | investorshub | 09/02/2020 3:09:44 PM |
Today is the turnaround. First Green Day in | Ckasper | investorshub | 09/02/2020 3:06:52 PM |
Theyll have to bring out news soon. Implementation | Ckasper | investorshub | 09/01/2020 2:29:03 PM |
Added a few more here.. | lakingsphan0427 | investorshub | 08/31/2020 4:48:51 PM |
NIH grant monies and full approval coming next | rstar | investorshub | 08/31/2020 11:43:32 AM |
Itll jump next week again, if they bring | Ckasper | investorshub | 08/30/2020 12:33:24 AM |
$FLDM | Hole shot King | investorshub | 08/29/2020 11:33:22 PM |
$FLDM Interview on Washington University's new Saliva COVID test | Hole shot King | investorshub | 08/29/2020 5:02:08 PM |
Just added a few more today.. | lakingsphan0427 | investorshub | 08/28/2020 3:54:49 PM |
I like it. Great find | Ckasper | investorshub | 08/28/2020 3:17:17 PM |
twitter https://www.marketbeat.com/instant-alerts/nasdaq-fldm-a-buy-or-sell-right-now-2020-08/ | Hole shot King | investorshub | 08/28/2020 3:10:24 PM |
Where did you see that? | Ckasper | investorshub | 08/28/2020 3:02:22 PM |
Sounds good to me.. | lakingsphan0427 | investorshub | 08/28/2020 2:12:20 PM |
Fluidigm $FLDM Price Target Raised to $16.00 at | Hole shot King | investorshub | 08/28/2020 12:47:31 PM |
Hoping for a good post market move, so | Ckasper | investorshub | 08/27/2020 7:36:55 PM |
Never stop learning lessons. Priceless. | Inspector121 | investorshub | 08/27/2020 7:01:23 PM |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...